Delivery Order SPE2DR25D1110-SPE2DR26F13GR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 6, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,808.64, with an ultimate completion date of December 8, 2025. The contract carries no set-aside designation and represents a competitively awarded transaction. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Ondansetron ODT 8 mg tablets in a quantity of 30-count packages, with a ceiling value of $1,733.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, and the delivery is scheduled for completion by June...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $1,151.04. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units, with a contract ceiling value of $7,608.34 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania corporate office. The delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract is a firm fixed price delivery order with a ceiling value of $11,416.54 and an ultimate completion date of December 12, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $14,188.55 and an ultimate completion date of October 8, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $1,840.13 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's ability...
- The Defense Logistics Agency awarded a $3,818.49 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. The product will be performed at the vendor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $4,180.69 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on December 9, 2025, with final delivery due by December 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement from the federal medical supply chain...
- SPE2DR25D1110Indefinite Delivery Contract
- SPE2DR25D1110-SPE2DR26F13GRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count packaging) with a ceiling value of $1,733.90. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by December 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a typical transaction under the company's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a diverse range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen regularly fulfills federal medical procurement requirements through open competition, demonstrating capability across therapeutic domains from specialty medications to generic drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/10/25 |